Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters











Publication year range
1.
J Mater Chem B ; 12(21): 5000-5023, 2024 May 29.
Article in English | MEDLINE | ID: mdl-38712692

ABSTRACT

Currently, the rapid spread of multidrug-resistant bacteria derived from the indiscriminate use of traditional antibiotics poses a significant threat to public health worldwide. Moreover, established bacterial biofilms are extremely difficult to eradicate because of their high tolerance to traditional antimicrobial agents and extraordinary resistance to phagocytosis. Hence, it is of universal significance to develop novel robust and efficient antibacterial strategies to combat bacterial infections. Micro/nanomotors exhibit many intriguing properties, including enhanced mass transfer and micro-mixing resulting from their locomotion, intrinsic antimicrobial capabilities, active cargo delivery, and targeted treatment with precise micromanipulation, which facilitate the targeted delivery of antimicrobials to infected sites and their deep permeation into sites of bacterial biofilms for fast inactivation. Thus, the ideal antimicrobial activity of antibacterial micro/nanorobots makes them desirable alternatives to traditional antimicrobial treatments and has aroused extensive interest in recent years. In this review, recent advancements in antibacterial micro/nanomotors are briefly summarized, focusing on their synthetic methods, propulsion mechanism, and versatile antibacterial applications. Finally, some personal insights into the current challenges and possible future directions to translate proof-of-concept research to clinic application are proposed.


Subject(s)
Anti-Bacterial Agents , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Bacteria/drug effects , Biofilms/drug effects , Microbial Sensitivity Tests , Nanostructures/chemistry , Bacterial Infections/drug therapy
2.
Can Respir J ; 2023: 8659293, 2023.
Article in English | MEDLINE | ID: mdl-37200921

ABSTRACT

The aim of our study was to examine the production of monocyte chemoattractant protein (MCP-4) and eotaxin-3 during the onset and progression of COPD. The expression levels of MCP-4 and eotaxin-3 were evaluated in COPD samples and healthy controls using immunostaining and ELISA. The relationship between the clinic pathological features in the participants and the expression of MCP-4 and eotaxin-3 were evaluated. The association of MCP-4/eotaxin-3 production in COPD patients was also determined. The results revealed enhanced production of MCP-4 and eotaxin-3 in COPD patients especially the cases with AECOPD in both bronchial biopsies and bronchial washing fluid samples. Furthermore, the expression signatures of MCP-4/eotaxin-3 show high AUC values in distinguishing COPD patients and healthy volunteers and AECOPD and stable COPD cases, respectively. Additionally, the number of MCP-4/eotaxin-3 positive cases was notably increased in AECOPD patients compared to those with stable COPD. Moreover, the expression of MCP-4 and eotaxin-3 was positively correlated in COPD and AECOPD cases. In addition, the levels of MCP-4 and eotaxin-3 could be increased in HBEs stimulated with LPS, which is a risk factor of COPD. Moreover, MCP-4 and eotaxin-3 may exert their regulatory functions in COPD by regulating CCR2, 3, and 5. These data indicated that MCP-4 and eotaxin-3 were potential markers for the clinical course of COPD, which could provide guidance for accurate diagnosis and treatment for this disease in future clinical practice.


Subject(s)
Monocyte Chemoattractant Proteins , Pulmonary Disease, Chronic Obstructive , Humans , Biomarkers , Chemokine CCL26 , Pulmonary Disease, Chronic Obstructive/diagnosis , Risk Factors
3.
Front Chem ; 10: 1084089, 2022.
Article in English | MEDLINE | ID: mdl-36531313

ABSTRACT

Ionic liquids have attracted attention due to their excellent properties and potential for use as co-solvents, solvents, co-catalysts, catalysts, and as other chemical reagents. This mini-review focuses on the properties and structures of ionic liquids, the pretreatment of lignocellulosic biomass, and the development of novel ionic liquid-based solid catalysts for cellulose and hemicellulose derived HMF production.

4.
Polymers (Basel) ; 14(17)2022 Sep 04.
Article in English | MEDLINE | ID: mdl-36080746

ABSTRACT

Lignocellulosic biomass as abundant, renewable, and sustainable carbon feedstock is an alternative to relieve the dependence on fossil fuels and satisfy the demands of chemicals and materials. Conversions of lignocellulosic biomass to high-value-added chemicals have drawn much attention recently due to the high availability of sustainable ways. This minireview surveys the recent trends in lignocellulosic biomass conversion into furan derivatives based on the following systems: (1) ionic liquids, (2) deep eutectic solvents, and (3) biphasic systems. Moreover, the current challenges and future perspectives in the development of efficient routes for lignocellulosic biomass conversion are provided.

5.
Chem Asian J ; 17(18): e202200566, 2022 Sep 14.
Article in English | MEDLINE | ID: mdl-35862657

ABSTRACT

Lignocellulose biomass (LCB) has extensive applications in many fields such as bioenergy, food, medicines, and raw materials for producing value-added products. One of the keys to efficient utilization of LCB is to obtain directly available oligo- and monomers (e. g., glucose). With the characteristics of easy recovery and separation, high efficiency, economy, and environmental protection, immobilized enzymes have been developed as heterogeneous catalysts to degrade LCB effectively. In this review, applications and mechanisms of LCB-degrading enzymes are discussed, and the nanomaterials and methods used to immobilize enzymes are also discussed. Finally, the research progress of lignocellulose biodegradation catalyzed by nano-enzymes was discussed.


Subject(s)
Biofuels , Nanostructures , Biomass , Catalysis , Hydrolysis , Lignin
6.
Front Chem ; 10: 884274, 2022.
Article in English | MEDLINE | ID: mdl-35665069

ABSTRACT

Microalgae are considered as the third-generation feedstock for biodiesel production, and lipid extraction plays a significant role in efficient production of biofuels. Numerous technologies including chemical, mechanical, and biological have been achieved but high efficiency and potential application on an industrial scale are still needed. This review discusses the factors that influence biodiesel quality and the relative green and sustainable solvents for lipid extraction.

7.
Bioresour Bioprocess ; 9(1): 124, 2022 Dec 05.
Article in English | MEDLINE | ID: mdl-38647643

ABSTRACT

Environmental problems such as greenhouse effect, the consumption of fossil energy, and the increase of human demand for energy are becoming more and more serious, which force researcher to turn their attention to the reduction of CO2 and the development of renewable energy. Unsafety, easy to lead to secondary environmental pollution, cost inefficiency, and other problems limit the development of conventional CO2 capture technology. In recent years, many microorganisms have attracted much attention to capture CO2 and synthesize valuable products directly. Fatty acid derivatives (e.g., fatty acid esters, fatty alcohols, and aliphatic hydrocarbons), which can be used as a kind of environmentally friendly and renewable biofuels, are sustainable substitutes for fossil energy. In this review, conventional CO2 capture techniques pathways, microbial CO2 concentration mechanisms and fixation pathways were introduced. Then, the metabolic pathway and progress of direct production of fatty acid derivatives from CO2 in microbial cell factories were discussed. The synthetic biology means used to design engineering microorganisms and optimize their metabolic pathways were depicted, with final discussion on the potential of optoelectronic-microbial integrated capture and production systems.

8.
J Environ Pathol Toxicol Oncol ; 40(4): 61-72, 2021.
Article in English | MEDLINE | ID: mdl-34936301

ABSTRACT

The aim of this study was to identify the roles of neuregulin 1 (NRG1) during the tumor progression in non-small-cell lung cancer (NSCLC). NSCLC patients with lung squamous cell carcinoma and lung adenocarci-noma were enrolled in this study. The expression of NRG1, vascular endothelial growth factor (VEGF) and surviving in clinical specimens was examined using immunohistochemistry analysis. The cytokine production in plasma was evaluated by ELISA. The levels of NRG1-associated molecules were determined using western blotting. The proliferation and apoptosis of cells with NRG1 knockdown were accessed by CCK-8 assay and flow cytometry. Upregulation of NRG1 as well as tumor-associated angiogenesis markers VEGF and survivin was detected in tissue and serum samples of NSCLC patients compared with the control. Furthermore, positive correlation with NSCLC levels and VEGF/survivin was also found in NSCLC specimens. In addition, upregulation of NRG1, VEGF and survivin was associated with poor overall survival in NSCLC patients. Moreover, enhanced production of NRG1 was detected in serum samples from NSCLC patients compared with healthy donors, and ROC analysis revealed the importance of NRG1 levels on distinguishing NSCLC samples and the controls. These findings suggested the novel diagnostic value of NRG1 in NSCLC. Additionally, upregulated protein levels of NRG1 and its target genes were also found in tissues samples of NSCLC patients compared with normal controls. These data indicated that NRG1 was a promising marker NSCLC, and it could be involved in tumor progression by targeting its downstream target including ErbB-Akt axis. Furthermore, the growth of lung cancer cells was suppressed by the knockdown of NRG1. Our findings could provide guidance for more accurate diagnosis for NSCLC, and future therapeutic approaches might be developed by better understanding of NRG-1-modulated molecular mechanisms during the tumor development in NSCLC.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma, Non-Small-Cell Lung/genetics , Lung Neoplasms/genetics , Neuregulin-1/genetics , Adult , Aged , Female , Humans , Male , Middle Aged , Neuregulin-1/metabolism
9.
Front Chem ; 9: 831102, 2021.
Article in English | MEDLINE | ID: mdl-35174143

ABSTRACT

The conversion of biomass into high-value chemicals through biorefineries is a requirement for sustainable development. Lignocellulosic biomass (LCB) contains polysaccharides and aromatic polymers and is one of the important raw materials for biorefineries. Hexose and pentose sugars can be obtained from LCB by effective pretreatment methods, and further converted into high-value chemicals and biofuels, such as 5-hydroxymethylfurfural (HMF), levulinic acid (LA), γ-valerolactone (GVL), ethyl levulinate (EL), and 5-ethoxymethylfurfural (EMF). Among these biofuels, EMF has a high cetane number and superior oxidation stability. This mini-review summarizes the mechanism of several important processes of EMF production from LCB-derived sugars and the research progress of acid catalysts used in this reaction in recent years. The influence of the properties and structures of mono- and bi-functional acid catalysts on the selectivity of EMF from glucose were discussed, and the effect of reaction conditions on the yield of EMF was also introduced.

10.
Hepatobiliary Pancreat Dis Int ; 14(1): 56-62, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25655291

ABSTRACT

BACKGROUND: Gadolinium chloride (GdCl3) selectively inactivates Kupffer cells and protects against ischemia/reperfusion and endotoxin injury. However, the effect of Kupffer cell inactivation on liver regeneration after partial liver transplantation (PLTx) is not clear. This study was to investigate the role of GdCl3 pretreatment in graft function after PLTx, and to explore the potential mechanism involved in this process. METHODS: PLTx (30% partial liver transplantation) was performed using Kamada's cuff technique, without hepatic artery reconstruction. Rats were randomly divided into the control low-dose (5 mg/kg) and high-dose (10 mg/kg) GdCl3 groups. Liver injury was determined by the plasma levels of alanine aminotransferase and aspartate aminotransferase, liver regeneration by PCNA staining and BrdU uptake, apoptosis by TUNEL assay. IL-6 and p-STAT3 levels were measured by ELISA and Western blotting. RESULTS: GdCl3 depleted Kupffer cells and decreased animal survival rates, but did not significantly affect alanine aminotransferase and aspartate aminotransferase (P>0.05). GdCl3 pretreatment induced apoptosis and inhibited IL-6 overexpression and STAT3 phosphorylation after PLTx in graft tissues. CONCLUSION: Kupffer cells may contribute to the liver regeneration after PLTx through inhibition of apoptosis and activation of the IL-6/p-STAT3 signal pathway.


Subject(s)
Gadolinium/pharmacology , Kupffer Cells/drug effects , Liver Regeneration/drug effects , Liver Transplantation/methods , Liver/surgery , Alanine Transaminase/blood , Animals , Apoptosis/drug effects , Aspartate Aminotransferases/blood , Biomarkers/blood , Dose-Response Relationship, Drug , Interleukin-6/metabolism , Kupffer Cells/metabolism , Liver/metabolism , Liver Transplantation/adverse effects , Male , Models, Animal , Phosphorylation , Rats , STAT3 Transcription Factor/metabolism , Signal Transduction/drug effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL